医药视界

投资者网
Jul 04, 2025

《投资者网》蔡俊国产创新药“忽如一夜春风来”。6月底,信达生物宣布完成约5.5亿美元的配股。同期,还有3家港股上市的创新药企宣布以同样方式进行融资,4家合计将超70亿元。同时,进入5月以来多家创新药企公开海外BD合作方案。似乎一夜之间,国产创新药的研发水准广受国际认可。资本与研发的双重利好下,政策层面也出台支持政策,创新药寒冬的周期有到了尽头的趋势。这一切,又是否具备持续性的真实?资本盛宴背后的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10